PAR
Click for more information
3.92% 26.5¢ paradigm biopharmaceuticals limited..

Ann: Final Director's Interest Notice, page-7

  1. bobsee
    230 Posts.
    lightbulb Created with Sketch. 28
    clock Created with Sketch.
    07/03/24
    11:35
    Post #: 72790502
    Exactly....very little commitment to the company financially and now there is with her replacements....

    PAR Price at posting: 37.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
right-arrow Created with Sketch.
NEWS The Telstra twist - What the job cuts decision mean for investors?
right-arrow Created with Sketch.
NEWS Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
SLS Historical prospects impress Solstice, with 25% copper and significant anomaly
right-arrow Created with Sketch.
DY6 DY6 Metals (ASX:DY6) shares soar as company flags historical rare earth hits
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.5¢ 		Change
0.010(3.92%) 		Mkt cap ! $92.69M
Open High Low Value Volume
26.5¢ 26.5¢ 25.5¢ $116.8K 445.0K

Buyers (Bids)

No. Vol. Price($)
2 79425 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.5¢ 17138 3
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
26.0¢ 		  Change
0.010 ( 0.58 %)
Open High Low Volume
26.0¢ 26.5¢ 26.0¢ 137056
Last updated 15.59pm 27/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.